These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2024552)

  • 1. Beneficial treatment with methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside in a patient with primary myelofibrosis.
    Asano Y; Shimokawa M; Okabe H; Sanefuji H; Kato K
    Acta Haematol; 1991; 85(2):103-4. PubMed ID: 2024552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Phase II study of methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside (MCNU)].
    Tanaka I; Kobayashi T; Shirakawa S; Ikeda Y; Kobayashi M; Yamagata K; Ohta K; Ohno R; Yamada H; Yamada K
    Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):493-8. PubMed ID: 3859248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor activity and toxicity of methyl 6-[3-(2-chloroethyl)- 3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside in experimental animals.
    Fujimoto S; Tashiro T; Ogawa M
    Gan; 1984 Oct; 75(10):937-46. PubMed ID: 6510639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Discriminant analysis of bone marrow suppression of methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside (MCNU)].
    Saito A; Oride M; Munaka M; Uozumi T
    Gan To Kagaku Ryoho; 1987 Feb; 14(2):511-5. PubMed ID: 3813579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurotoxicity and pharmacokinetics of ventriculolumbar perfusion of methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside (MCNU) in dogs.
    Kochi M; Takaki S; Kuratsu J; Seto H; Kitamura I; Ushio Y
    J Neurooncol; 1994; 19(3):239-44. PubMed ID: 7807174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new nitrosourea derivative for the treatment of chronic myelogenous leukemia.
    Hiraoka A; Masaoka T; Shibata H; Miyazaki T; Nakamura T; Yasunaga K; Kitani T; Yonezawa T; Kawagoe H; Horiuchi A
    Leuk Res; 1988; 12(6):487-90. PubMed ID: 3043111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Phase II study with methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside (MCNU) in hematological malignancies].
    Higuchi A; Miyazaki T; Sakurada K; Morioka M; Musashi M; Imamura M; Maekawa I; Saitoh H; Ohtani N; Kasai M
    Gan To Kagaku Ryoho; 1985 Jun; 12(6):1253-9. PubMed ID: 3859250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Randomized controlled study of methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside (MCNU) in comparison with busulfan for chronic myelogenous leukemia].
    Masaoka T; Kimura K; Miyazaki T; Hirota Y; Nakamura T; Yasunaga K; Ohkubo H; Okamoto Y; Fujitake H; Kitani T
    Gan To Kagaku Ryoho; 1985 May; 12(5):1111-8. PubMed ID: 3888116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Phase II study of a new nitrosourea derivative, MCNU, in tablet form. Takai Blood Cancer Study Group].
    Kobayashi T; Tanaka I; Shirakawa S; Fujiwara Y; Hirota Y; Kobayashi M; Ohno R; Yamada H; Mitomo Y; Yamamoto M
    Gan To Kagaku Ryoho; 1987 Apr; 14(4):1079-85. PubMed ID: 3566304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The use of MCNU to a patient of primary myelofibrosis complicated with pericardial effusion and proteinuria].
    Shiga Y; Matsuoka R; Abe R; Matsuda S; Uchida T; Kariyone S
    Rinsho Ketsueki; 1989 Apr; 30(4):497-501. PubMed ID: 2769970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biologic activity of MCNU: a new antitumor agent.
    Sekido S; Ninomiya K; Iwasaki M
    Cancer Treat Rep; 1979 Jun; 63(6):961-70. PubMed ID: 466655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Phase II study on MCNU in patients with advanced or recurrent gastrointestinal cancer].
    Niimoto M; Yoshinaka K; Hattori T; Kobayashi S; Hosoma S; Ogawa Y; Iwamori S; Nagata N; Yamagata S; Nishimawari K
    Gan To Kagaku Ryoho; 1985 Sep; 12(9):1813-9. PubMed ID: 4037810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prolonged remission in a patient with chronic myelocytic leukemia (CML) by methyl 6-[3-(2-chloroethyl)-3-deoxy-alpha-D-glucopyranoside (MCNU)].
    Murase T; Nagura E; Ohno R
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2590-3. PubMed ID: 6594976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the nitrosourea anti-tumor chemotherapeutical agent MCNU on five human myeloma cell lines.
    Otsuki T; Sakaguchi H; Yamada O; Yawata Y; Ueki A
    Oncol Rep; 1998; 5(4):827-32. PubMed ID: 9625826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of high-dose MCNU therapy and hematopoietic stem cell autografts treatment of childhood acute leukemia/lymphoma with high-risk features.
    Takaue Y; Watanabe T; Hoshi Y; Abe T; Matsunaga K; Saito S; Hirao A; Kawano Y; Ninomiya T; Kuroda Y
    Cancer; 1991 Apr; 67(7):1830-7. PubMed ID: 1672260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Action mechanism of methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside (MCNU) in leukemic cells].
    Nakamura T; Hashimoto E; Sasada M; Tsutani H; Kagawa D; Ueda T; Uchida M; Domae N; Ando S; Uchino H
    Nihon Ketsueki Gakkai Zasshi; 1985 May; 48(3):734-41. PubMed ID: 3862320
    [No Abstract]   [Full Text] [Related]  

  • 17. [Phase I study on oral administration of methyl-6-[[[(2-chloroethyl) nitrosoamino] carbonyl] amino]-6-deoxy-alpha-D-glucopyranoside (MCNU)].
    Kanamaru A; Nagai K; Fujita S; Masaoka T; Takubo T; Kitani T; Taniguchi N; Horiuchi A; Tsubaki K; Kawagoe H; Hirata M; Yonezawa T; Tsubakio T; Yasunaga K; Okamoto Y; Fujitake H; Ohkubo A
    Gan To Kagaku Ryoho; 1983 Aug; 10(8):1831-7. PubMed ID: 6882006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurotoxicity of local administration of two nitrosoureas in malignant gliomas.
    Yamashima T; Yamashita J; Shoin K
    Neurosurgery; 1990 May; 26(5):794-9. PubMed ID: 2352597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Phase II study with methyl-6[[[2-chloroethyl) nitrosoamino] carbonyl] amino]-6-deoxy-alpha-D-glucopyranoside (MCNU) in hematological malignancies].
    Masaoka T; Kimura K; Miyazaki T; Sakurada K; Saitoh H; Morioka M; Fujimoto N; Musashi M; Wakui A; Yokoyama M; Kanamaru R; Oguro M; Takagi T; Konda C; Saitoh T; Nakao I; Harashima S; Ohhashi Y; Sakai Y; Sasaki T; Ohno R; Katoh Y; Yamada K; Hirota Y; Takada T; Hoshino A; Ohara K; Kamiya O; Kojima T; Nagata K; Nakamura T; Sasada M; Yonezawa T; Tsubakio T; Kanayama Y; Kitani T; Taniguchi N; Yasunaga K; Okamoto Y; Fujitake H; Ohkubo A; Horiuchi A; Tsubaki K; Takubo T; Shibata H; Kawagoe H; Hirata M; Matsubuchi T; Nagai K; Fujita S
    Gan To Kagaku Ryoho; 1983 Jun; 10(6):1518-23. PubMed ID: 6347081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of antitumor activities of nitrosourea derivatives against mammary breast carcinoma (MX-1) in nude mice.
    Inoue K; Fujimoto S; Ogawa M
    Gan; 1980 Oct; 71(5):686-91. PubMed ID: 7227717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.